Tomohide Tanabe

Antifibrotic effect and long‐term outcome of SGLT2 inhibitors in patients with NAFLD complicated by diabetes mellitus

Taeang Arai, Masanori Atsukawa, Akihito Tsubota et al. · Hepatology Communications · 2022 · 49 citations · Full text

Pathology, Pharmacotherapy, Fatty Liver Disease +20

Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease

Taeang Arai, Masanori Atsukawa, Akihito Tsubota et al. · Scientific Reports · 2021 · 32 citations · Full text

Effect of sodium-glucose cotransporter 2 inhibitor in patients with non-alcoholic fatty liver disease and type 2 diabetes mellitus: a propensity score-matched analysis of real-world data

Taeang Arai, Masanori Atsukawa, Akihito Tsubota et al. · Therapeutic Advances in Endocrinology and Metabolism · 2021 · 29 citations · Full text

Efficacy of long-term maintenance therapy with 10-mg vonoprazan for proton pump inhibitor-resistant reflux esophagitis

Tomohide Tanabe, Shintaro Hoshino, Noriyuki Kawami et al. · Esophagus · 2019 · 27 citations

Esophagus, Medicine, Gastroenterology +5

Efficacy of on-demand therapy using 20-mg vonoprazan for non-erosive reflux disease

Yoshimasa Hoshikawa, Noriyuki Kawami, Shintaro Hoshino et al. · Esophagus · 2019 · 19 citations

20-Mg Vonoprazan, On-demand Therapy, Non-erosive Reflux Disease +4